Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Sadif Analytics Prime
$10.00
Provider: Reuters Investment Profile
$20.00
Provider: Sadif Analytics Prime
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Miraca Holdings Inc Announces Merger between Subsidiary and Sub-subsidiary


Tuesday, 23 Jul 2013 02:15am EDT 

Miraca Holdings Inc announced that its Tokyo-based wholly owned subsidiary FUJIREBIO Inc. will merge with a Tokyo-based wholly owned subsidiary of FUJIREBIO, effective April 1, 2014. As a result, FUJIREBIO will be the surviving company and the subsidiary of FUJIREBIO will be dissolved. The two companies are both engaged in clinical test agent business. 

Company Quote

5160.0
0.0 +0.00%
26 Dec 2014